Cover Image
Market Research Report

Global Medical Marijuana Market Research Report Forecast to 2023

Published by Market Research Future Product code 911163
Published Content info 115 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Medical Marijuana Market Research Report Forecast to 2023
Published: August 31, 2019 Content info: 115 Pages
Description

Global Medical Marijuana Market: Information by Product Type (Solid, Gas and Dissolvable/Powders), Application (Alzheimer's Disease, Cancer, Schizophrenia and Multiple Sclerosis), Distribution Channel (Retail & Pharmacy Stores, Online Platforms) and Region - Forecast till 2023

Market analysis

To reach attain USD 54,677.1 million by the year 2023, Global Medical Marijuana Market is predicted to list a CAGR of 34.0%.

Marijuana is a plant having some chemical composite "cannabis" that has medical property. Number of pharmaceutical companies use this plant as a raw material to manufacture drugs for numerous therapeutic applications. Marijuana plants abstracts are also useful to treat the disease and various conditions caused by the disease such as the central nervous system, cancer, Alzheimer's and used in anti-aging products.

The increasing prevalence of chronic diseases, mounting therapeutic applications of the marijuana plant, rising acceptance of marijuana for medical treatment in many countries, and cumulative authorization of marijuana are predicted to push the market growth. The global medical marijuana market has been mainly driven by the growing research and development activities and financial support by several private and government organizations for cannabinoid research

However, some factors may detain the market growth during the forecast period such as the wide-ranging approval procedures, laborious government policies, and growing illegal use of marijuana.

America held the largest market share in 2017 and the regional market is expected to list a CAGR of 34.0% during the forecast period. Due to the increasing prevalence of Alzheimer disease, cancer, and others American is anticipated to hold the largest market share. Europe is likely to be the second largest market share, with 5.5% from the global medical marijuana market, and the projected fastest growing market is Asia-Pacific.

Envisioned Onlookers are Research Institutes and Academic Centers, Pharmaceutical Companies, Market Research and Consulting, Healthcare Providers, Government Associations, Medical Marijuana Manufacturers,

Market segmentation

The segmentation is based on 4 parts. The first part is Global Medical Marijuana Market, by Product Type that has been divided into 4 segments i.e. Ointments & Creams, Dissolvable/ Powders, Ointments & creams. Then second part is Global Medical Marijuana Market, by Application that includes Alzheimer's Disease, Cancer, Schizophrenia, Multiple Sclerosis. Third segmentation is made on Distribution Channel that includes Retail & Pharmacy Stores, Online Platforms, Others. The last segmentation is based on Region that includes Americas covering North America (US, Canada) and South America, Europe covering Western Europe (Germany, UK, France, Italy, Spain, Rest of Western Europe) and Eastern Europe, Asia-Pacific covering China, Japan, India, Australia, South Korea, Rest of Asia-Pacific, Middle East & Africa covering Middle East and Africa.

Regional Analysis

The global medical marijuana market, based on region, is divided into the Americas, Europe, Asia-Pacific and the Middle East and Africa.

Major Players

Cannabis Sativa Inc (Nevada), GEmerald Health Therapeutics Inc. (Victoria, BC), Tilray (Nanaimo, BC), Canopy Growth Corporation (US), Aphria (Ontario), (Nevada) and MediPharm Labs (US) CanniMed Ltd (Canada), Cara Therapeutics (US), Pfizer Inc. (US), Medical Marijuana Inc (US), GBSciences Inc., W Pharmaceuticals Plc (US), are Some of the eminent players in the global medical marijuana market.

Table of Contents

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Scope of Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Growing research and development activities and financial support by various private and government organizations for cannabinoid research
    • 4.2.2 Rising prevalence of chronic diseases and other medical conditions
    • 4.2.3 Increasing authorization of marijuana for medical applications
  • 4.3 Restraints
    • 4.3.1 Stringent government policies
    • 4.3.2 Increasing illegal use of marijuana
    • 4.3.3 Side-effects after the intense use of marijuana
  • 4.4 Challenges
    • 4.4.1 Change in government regulations for the use of cannabis for medical applications

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 Overview
    • 5.1.2 R&D
    • 5.1.3 Manufacturing
    • 5.1.4 Distribution & Sales
    • 5.1.5 Post-Sales Monitoring
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Overview
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Bargaining Power of Buyers
    • 5.2.4 Threat of New Entrants
    • 5.2.5 Threat of Substitutes
    • 5.2.6 Intensity of Rivalry

6 Global Medical Marijuana Market, by Product Type

  • 6.1 Introduction
  • 6.2 Solids
  • 6.3 Dissolvables/Powders
  • 6.4 Oil
  • 6.5 Ointments & Creams

7 Global Medical Marijuana Market, by Application

  • 7.1 Introduction
  • 7.2 Alzheimer's Disease
  • 7.3 Cancer
  • 7.4 Schizophrenia
  • 7.5 Multiple Sclerosis

8 Global Medical Marijuana Market, by Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail & Pharmacy Stores
  • 8.3 Online Platforms

9 Global Medical Marijuana Market, by Region

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 US
      • 9.2.1.2 Canada
    • 9.2.2 South America
  • 9.3 Europe
    • 9.3.1 Western Europe
      • 9.3.1.1 Germany
      • 9.3.1.2 UK
      • 9.3.1.3 France
      • 9.3.1.4 Italy
      • 9.3.1.5 Spain
      • 9.3.1.6 Rest of Western Europe
    • 9.3.2 Eastern Europe
  • 9.4 Asia-Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Republic of Korea
    • 9.4.6 Rest of Asia-Pacific
  • 9.5 Rest of the World

10 Competitive Landscape

11 Company Profile

  • 11.1 Canopy Growth Corporation
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products/Services Offered
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Strategy
  • 11.2 Cannabis Sativa Inc.
    • 11.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products/Services Offered
    • 11.2.4 Key Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Strategy
  • 11.3 GW Pharmaceuticals Plc
    • 11.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products/Services Offered
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategy
  • 11.4 Emerald Health Therapeutics Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products/Services Offered
    • 11.4.4 Key Developments
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Strategy
  • 11.5 Tilray
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products/Services Offered
    • 11.5.4 Key Developments
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Strategy
  • 11.6 Aphria
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products/Services Offered
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategy
  • 11.7 CanniMed Ltd
    • 11.7.1 Company Overview
    • 11.7.2 Financial Overview
    • 11.7.3 Products/Services Offered
    • 11.7.4 Key Developments
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Strategy
  • 11.8 Cara Therapeutics
    • 11.8.1 Company Overview
    • 11.8.2 Financial Overview
    • 11.8.3 Pipeline Products
    • 11.8.4 Key Developments
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Strategy
  • 11.9 Pfizer Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Overview
    • 11.9.3 Clinical Trial Products
    • 11.9.4 Key Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Strategy
  • 11.1 Medical Marijuana Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Financial Overview
    • 11.10.3 Products/Services Offered
    • 11.10.4 Key Developments
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Strategy
  • 11.11 GBSciences Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Financial Overview
    • 11.11.3 Pipeline Products
    • 11.11.4 Key Developments
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Strategy
  • 11.12 MediPharm Labs
    • 11.12.1 Company Overview
    • 11.12.2 Financial Overview
    • 11.12.3 Products/Services Offered
    • 11.12.4 Key Developments
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Strategy

12 Appendix

  • 12.1 Discussion Blue Print

List of Tables

  • TABLE 1 LIST OF ASSUMPTIONS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR SOLIDS 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR DISSOLVABLES/POWDERS 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR OIL 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR OINTMENTS & CREAMS 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR ALZHEIMER'S DISEASE 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR CANCER 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR SCHIZOPHRENIA 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR MULTIPLE SCLEROSIS 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR RETAIL & PHARMACY STORES 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION, FOR ONLINE PLATFORMS 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION 2015-2023 (USD MILLION)
  • TABLE 17 AMERICAS: MEDICAL MARIJUANA MARKET BY REGION 2015-2023 (USD MILLION)
  • TABLE 18 AMERICAS: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 19 AMERICAS: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 21 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 22 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 23 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 24 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 25 US: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 26 US: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 27 US: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 28 CANADA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 29 CANADA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 30 CANADA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 31 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 32 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 33 SOUTH AMERICA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 34 EUROPE: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2015-2023 (USD MILLION)
  • TABLE 35 EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 36 EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 37 EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 38 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2015-2023 (USD MILLION)
  • TABLE 39 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 40 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 41 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 42 GERMANY: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 43 GERMANY: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 44 GERMANY: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 45 UK: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 46 UK: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 47 UK: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 48 FRANCE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 49 FRANCE: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 50 FRANCE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 51 ITALY: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 52 ITALY: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 53 ITALY: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 54 SPAIN: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 55 SPAIN: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 56 SPAIN: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 57 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 58 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 59 REST OF WESTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 60 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 61 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 62 EASTERN EUROPE: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 63 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2015-2023 (USD MILLION)
  • TABLE 64 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 65 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 66 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 67 JAPAN: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 68 JAPAN: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 69 JAPAN: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 70 CHINA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 71 CHINA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 72 CHINA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 73 INDIA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 74 INDIA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 75 INDIA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 76 AUSTRALIA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 77 AUSTRALIA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 78 AUSTRALIA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 79 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 80 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 81 REPUBLIC OF KOREA: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 82 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 83 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 84 REST OF ASIA-PACIFC: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 85 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 86 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY APPLICATION 2015-2023 (USD MILLION)
  • TABLE 87 REST OF THE WORLD: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
  • TABLE 88 GLOBAL MEDICAL MARIJUANA MARKET MAJOR PLAYERS 2017

List of Figures

  • FIGURE 1 GLOBAL MEDICAL MARIJUANA MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 SUPPLY CHAIN: GLOBAL MEDICAL MARIJUANA MARKET
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MEDICAL MARIJUANA MARKET
  • FIGURE 6 GLOBAL: MEDICAL MARIJUANA MARKET BY PRODUCT TYPE 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL: MEDICAL MARIJUANA MARKET BY APPLICATION 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL: MEDICAL MARIJUANA MARKET BY DISTRIBUTION CHANNEL 2017 & 2023 (USD MILLION)
  • FIGURE 9 GLOBAL: MEDICAL MARIJUANA MARKET BY REGION 2017 (%)
  • FIGURE 10 AMERICAS MEDICAL MARIJUANA MARKET BY REGION 2017 (%)
  • FIGURE 11 NORTH AMERICA: MEDICAL MARIJUANA MARKET BY COUNTRY 2017 (%)
  • FIGURE 12 EUROPE: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2017 (%)
  • FIGURE 13 WESTERN EUROPE: MEDICAL MARIJUANA MARKET BYCOUNTRY/ REGION 2017 (%)
  • FIGURE 14 ASIA-PACIFIC: MEDICAL MARIJUANA MARKET BY COUNTRY/REGION 2017 (%)
Back to Top